Holiday Demand Marks Monport’s Mission to Support Expanding Craft on Custom Laser Engraving
NEW YORK, Dec. 12, 2025 /PRNewswire/ — The holiday season has sparked renewed interest in the tools behind today’s personalization boom, with many creators... Read more.
DELAWARE COURT REVERSES PRIOR JUDGEMENT OF $1 BILLION DAMAGES AGAINST BYJU RAVEENDRAN
BENGALURU, India and NEW DELHI , Dec. 12, 2025 /PRNewswire/ — The Delaware Court has reversed the $1 billion Judgement against Byju Raveendran (Director,... Read more.
Insilico Medicine and TaiGen Achieves License Agreement to Develop and Commercialize AI-driven PHD Inhibitor for Anemia of Chronic Kidney Disease (CKD)
Insilico Medicine has licensed TaiGen Biotechnology exclusive rights in the Greater China area to develop, commercialize, and sub-license ISM4808, an AI-driven potential... Read more.
Marengo to Present Initial Results from Invikafusp Alfa and TRODELVY® Combination Study, STARt-002, at the 2025 San Antonio Breast Cancer Symposium
Safety profile of Invikafusp alfa + TRODELVY® is consistent with the known profiles of each agent Invikafusp alfa demonstrates selective expansion of Vβ6/10 T... Read more.
10 Weeks, $1 Billion in Trading Volume: Byreal Redefines DeFi Growth Model on Solana
DUBAI, UAE, Dec. 12, 2025 /PRNewswire/ — Byreal, a decentralized exchange (DEX) incubated by Bybit and built for the Solana ecosystem, once again demonstrated... Read more.
Global Push Toward Recyclable Packaging Accelerates Monomaterial PE Solution Market to USD 5.7 Billion by 2035
NEWARK, Del., Dec. 11, 2025 /PRNewswire/ — The global monomaterial PE solution market is set to grow from USD 3.0 billion in 2025 to USD 5.7 billion by 2035,... Read more.
Singtel Receives Frost & Sullivan’s 2025 Singapore Company of the Year Recognition in Cybersecurity Services Leadership
Singapore’s national leader in integrated cyber resilience is acknowledged for driving measurable market impact, innovation, and customer-first security transformation.... Read more.
Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion
Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera and to be marketed by STADA Recommendation... Read more.
/R E P E A T — Media Advisory – PS Naqvi to speak at Energy Modelling Hub Annual Forum 2025/
OTTAWA, ON, Dec. 11, 2025 /CNW/ – Yasir Naqvi, Parliamentary Secretary to the Minister of International Trade and to the Secretary of State (International... Read more.
Orphalan announces acquisition of Orphelia Pharma
PARIS, Dec. 12, 2025 /PRNewswire/ — Orphalan, an international pharmaceutical company specializing in the development and commercialization of orphan drugs,... Read more.